Matches in Wikidata for { <http://www.wikidata.org/entity/Q63398179> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q63398179 description "clinical trial" @default.
- Q63398179 description "ensayu clínicu" @default.
- Q63398179 description "klinisch onderzoek" @default.
- Q63398179 description "клінічне випробування" @default.
- Q63398179 name "Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer" @default.
- Q63398179 type Item @default.
- Q63398179 label "Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer" @default.
- Q63398179 prefLabel "Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer" @default.
- Q63398179 P1132 Q63398179-A060448D-07CC-429E-BAF8-78C008F70669 @default.
- Q63398179 P1476 Q63398179-DCB5971A-081B-4F7D-ABF7-4314048B9465 @default.
- Q63398179 P17 Q63398179-F84CA390-CBAB-49F9-9726-7F56D5A2558E @default.
- Q63398179 P2899 Q63398179-4A1871A2-A611-41A5-B165-BB8AD96F0A5A @default.
- Q63398179 P3098 Q63398179-7EF607C2-EF1F-4873-8286-06CAED5969D6 @default.
- Q63398179 P31 Q63398179-61C7B354-B406-4BC9-83E1-F510DBEBE47C @default.
- Q63398179 P4844 Q63398179-2FF80F8E-0104-48A7-A3E0-F4F49F96A2E0 @default.
- Q63398179 P580 Q63398179-B273DC67-3FF0-47B2-BD2D-ED6CD83D8512 @default.
- Q63398179 P582 Q63398179-EE92B81E-8616-44BA-9D0E-250EA66DF920 @default.
- Q63398179 P6099 Q63398179-130718CC-0992-4331-93F3-0AA59ED98935 @default.
- Q63398179 P6099 Q63398179-5C4CBF41-974A-4343-87FF-0B2C54FEB68B @default.
- Q63398179 P6153 Q63398179-CC337AF4-50C5-431E-9246-1A75A1C0E5C0 @default.
- Q63398179 P8329 Q63398179-D53E248F-6AC1-4B88-88DC-74630727CAF2 @default.
- Q63398179 P8363 Q63398179-1CC4A89E-06F8-4143-9F67-608C248D4D7E @default.
- Q63398179 P859 Q63398179-F268A6C5-97F4-4E63-8517-7E959A0C82EC @default.
- Q63398179 P1132 "+92" @default.
- Q63398179 P1476 "BRE 17107: A Phase Ib/II Trial of Atezolizumab (an Anti-PD-L1 Monoclonal Antibody) With Cobimetinib (a MEK1/2 Inhibitor) or Idasanutlin (an MDM2 Antagonist) in Metastatic ER+ Breast Cancer" @default.
- Q63398179 P17 Q30 @default.
- Q63398179 P2899 "+18" @default.
- Q63398179 P3098 "NCT03566485" @default.
- Q63398179 P31 Q30612 @default.
- Q63398179 P4844 Q20707748 @default.
- Q63398179 P580 "2018-06-25T00:00:00Z" @default.
- Q63398179 P582 "2023-07-01T00:00:00Z" @default.
- Q63398179 P6099 Q42824440 @default.
- Q63398179 P6099 Q5452194 @default.
- Q63398179 P6153 Q29052 @default.
- Q63398179 P8329 Q88735089 @default.
- Q63398179 P8363 Q78089383 @default.
- Q63398179 P859 Q43079570 @default.